Acute coronary syndromes (ACS) remain a leading cause of morbidity and mortality worldwide, encompassing a broad spectrum of clinical entities surrounded by distinct pathophysiological mechanisms, clinical presentations, treatment strategies and outcomes. A rapid recognition of these conditions and a thorough patient risk stratification are pivotal elements for tailoring diagnostic and therapeutic approaches with the final goal to improve survival. Over the past decades, advances in interventional cardiology have revolutionized the acute treatment of ACS, enabling prompt and safe revascularization. Following the acute phase, pharmacological regimens aimed at minimizing recurrent ischemic events and mitigating bleeding risk become central in the long-term management. Within this broad spectrum of ACS, certain complex scenarios, including critical presentations such as cardiogenic shock, and the management of high-risk subgroups such as frail individuals or those with multiple comorbidities, require personalized strategies and specialized care. This book bridges current evidence with emerging frontiers in the management of ACS, providing clinicians, interventional cardiologists and cardiovascular researchers with a comprehensive resource on the latest standards and innovations in the field.
